Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Single-stranded DNA-binding protein 4 is a DNA-binding protein encoded by the SSBP4 gene in humans. It binds tightly to single-stranded DNA and is predicted to be involved in positive regulation of transcription by RNA polymerase II. SSBP4, like other members of the single-stranded DNA-binding protein family, is likely active in the nucleus, where it stabilizes single-stranded DNA regions and may play a role in transcription regulation. An important paralog of SSBP4 is SSBP3. Diseases associated with SSBP4 include childhood kidney cell carcinoma and branchiootorenal syndrome 1. No drugs or therapeutics are known to interact directly with SSBP4, nor is it currently considered a therapeutic target.
Not applicable; no drugs are known to target SSBP4
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Single-stranded DNA-binding protein 4 (SSBP4).